Skip to main content

$0.100 -0.005 (-4.76%)

High

$0.11

Low

$0.10

Trades

225

Turnover

$176,834

Volume

1,754,344
30 June 2023 at 4:10pm
Register to track IHL and receive email alerts.
Subject
IHL Ann: Change of Director's Interest Notice

IHL Ann: Change of Registered Office

IHL Ann: IHL Announcement - H.C. Wainwright Virtual Conference

IHL Ann: Principal Investigators Appointed for IHL42X Phase 2/3 Trial

IHL Ann: Change of Director's Interest Notice

IHL Ann: Notification regarding unquoted securities - IHL

IHL Ann: International Psychedelics Experts Join Clarion Clinics

IHL Ann: Entitlement Offer of Loyalty Options Oversubscribed

IHL Ann: Psychennex Pty Ltd - Company Update

IHL Ann: Lease Secured for Psychedelic Clinic

IHL Ann: IHL-675A Phase 1 Results Presentation

IHL Ann: Non-Renounceable Issue

IHL Ann: Incannex Announces Final Results from Phase 1 Clinical Trial

IHL Ann: Quarterly Activities/Appendix 4C Cash Flow Report

IHL Ann: Proposed issue of securities - IHL

IHL Ann: Cancel - Proposed issue of securities - IHL

IHL Ann: Proposed issue of securities - IHL

IHL Ann: Entitlement Offer of Loyalty Options

IHL Ann: Global CRO leader QPS engaged for CannQuit & ReneCann

IHL Ann: Incannex Launches Psychedelic Clinics Business

IHL Ann: Reinstatement to Official Quotation

IHL Ann: Interim phase 2 PsiGAD psilocybin results

IHL Ann: Voluntary Suspension

IHL Ann: Trading Halt

IHL Ann: Pause in Trading

IHL Ann: Incannex to Manufacture Psilocybin for Trials & Commercial

IHL Ann: IHL Commences Phase 2 Clinical Trial

IHL Ann: Appendix 4D and Half Year Accounts

IHL Ann: Quarterly Activities/Appendix 4C Cash Flow Report

IHL Ann: Independent data review commences for Ph 2 trial psilocybin

IHL Ann: Appendix 3Y R Clark

IHL Ann: Notification regarding unquoted securities - IHL

IHL Ann: Proposed issue of securities - IHL

IHL Ann: Cleansing Statement

IHL Ann: Notification regarding unquoted securities - IHL

IHL Ann: Application for quotation of securities - IHL

IHL Ann: Incannex Expands Intellectual Property Position over IHL-42X

IHL Ann: Prospectus for Placement Options

IHL Ann: Proposed issue of securities - IHL

IHL Ann: Capital Raising Presentation

IHL Ann: Incannex Undertakes A$13 Million Institutional Placement

IHL Ann: Trading Halt

IHL Ann: Results of Meeting

IHL Ann: IHL Annual General Meeting CEO Address

IHL Ann: IHL commences manufacturing of skin therapeutics

IHL Ann: IHL Commences Manufacturing for Novel Addiction Treatments

IHL Ann: Addendum to Notice of Annual General Meeting

IHL Ann: Incannex Development Update for IHL-42X

IHL Ann: Incannex files Form 20-F and XBRL Data with SEC

IHL Ann: Quarterly Activities/Appendix 4C Cash Flow Report

Register to track IHL and receive email alerts.

Similar Companies

CAN
CPH
EOF
MVP
MYX
NEU
PBP
RCE
SPL